1-4 of 4
Miroslav Prucha
Close
Sort by
Journal Articles

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Sona Pekova, M.D., PhD., Michal Dvorak, PhD., Robert Ivanek, Sabrina Rueggeberg, Stefan Leicht, Tomas Kozak, MD, PhD, Jiri Vrba, MD., Jiri Schwarz, MD., PHD., Petr Cetkovsky, MD., PHD., Miroslav Prucha, MD., PHD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 4480.
https://doi.org/10.1182/blood.V112.11.4480.4480
Published: 2008
Journal Articles

Delta Ex6, the Novel Transactivation-Defective Splicing Variant of p53 Gene, Is Differentially Expressed in Patients with Chronic Lymphocytic Leukemia and Confers Accented Proliferative Phenotype in Vitro

Sona Pekova, M.D., PhD., Radek Cmejla, PhD, Tomas Kozak, MD, PhD, Lukas Smolej, MD, PhD, Martin Spacek, MD., Miroslav Prucha, MD., PhD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 3795.
https://doi.org/10.1182/blood.V112.11.3795.3795
Published: 2008
Journal Articles

Mutation JAK2 V617F in Patients with Myeloproliferative Disorders and Technical Aspects of Its Detection.

Sona Pekova, Rudolf Hoffmann, Pavel Jindra, Ludmila Novakova, Tomas Kozak, Vera Vozobulova, Miroslava Schutzova, Jozef Balasz, Lucie Tomsikova, Miroslav Prucha
Journal: Blood
Blood (2006) 108 (11): 4906.
https://doi.org/10.1182/blood.V108.11.4906.4906
Published: 2006
Journal Articles

Quantitation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia Using LNA-Modified Fluorescently Labeled Probes and Real-Time PCR Technology.

Sona Pekova, Ludmila Saudkova, Lukas Smolej, Miroslav Prucha, Tomas Kozak
Journal: Blood
Blood (2006) 108 (11): 2331.
https://doi.org/10.1182/blood.V108.11.2331.2331
Published: 2006